{
  "id": "cluster_6_doc2",
  "content": "Blue Cross policy PX-4892-RW introduced new prior authorization requirements for biologic asthma medications in July 2023. The change affects patients over 6 years old, requiring documented failure of two corticosteroid inhalers. Pediatric pulmonologists reported adapting treatment plans accordingly.",
  "metadata": {
    "format": "policy_document"
  }
}